<DOC>
	<DOCNO>NCT02201862</DOCNO>
	<brief_summary>This study conduct provide clinically annotated sample support continue improvement Ariosa Test content , methodology , specimen process quality control .</brief_summary>
	<brief_title>Non-Invasive Chromosomal Evaluation Trisomy Study</brief_title>
	<detailed_description />
	<mesh_term>Down Syndrome</mesh_term>
	<mesh_term>Aneuploidy</mesh_term>
	<mesh_term>Trisomy</mesh_term>
	<criteria>1 . Subject least 18 year old provide inform consent ; 2 . Subject viable singleton twin pregnancy ; 3 . Subject confirm least 10 week , 0 day gestation time study blood draw ; 4 . Subject plan undergo CVS and/or amniocentesis purpose genetic analysis fetus OR subject already undergone CVS and/or amniocentesis know fetus chromosomal abnormality confirm genetic analysis . 1 . Subject know aneuploidy ; 2 . Subject pregnant two fetus sonographic evidence three gestational sac time pregnancy ; 3 . Subject fetal demise ( include natural elective reduction ) identify prior consent ; 4 . Subject history malignancy treat chemotherapy and/or major surgery , bone marrow transplant ;</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Aneuploidy</keyword>
	<keyword>Down Syndrome</keyword>
	<keyword>amniocentesis</keyword>
	<keyword>chronic villus sample</keyword>
	<keyword>Trisomy</keyword>
	<keyword>non-invasive prenatal testing</keyword>
	<keyword>Chromosome disorder</keyword>
</DOC>